Key result
Geographic TAVR growth and distance-to-care interact with 30-day mortality among Medicare beneficiaries.
Why the study?
Although TAVR has grown significantly throughout the US, the extent to which access to care has changed and the interaction between geographic TAVR growth, distance-to-care, and 30-day mortality remained unknown.
Answers are grounded in this paper and cite their sources.
Travel distance to TAVR may affect 30-day mortality; leaves open equitable access strategies pending prospective validation.
TAVR has grown significantly throughout the US but the extent to which access to care has changed remains unknown. In this analysis, we assess the interaction between geographic TAVR growth, distance-to-care (DTC), and 30-day mortality. The 100% MedPAR File from 2012-2017 was queried to identify
No takes yet. Share an insight, caveat, or question.
Young et al. (2020) studied this question. Geographic transcatheter aortic valve replacement growth and distance-to-care were evaluated for their interaction with 30-day mortality among US Medicare beneficiaries from 2012 to 2017.
Synapse has enriched 10 related papers. Consider them for comparative context: